Preeclampsia Postpartum Antihypertensive Treatment
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 300 participants.
Also called NCT04298034
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT04298034
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04298034. Randomized; single masking; primary purpose treatment. Start 2020-07-17 (actual); primary completion 2025-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Preeclampsia Postpartum Antihypertensive Treatment
- Acronym
- P-PAT
- Condition
- Preeclampsia
- Condition
- Hypertension in Pregnancy
- Intervention (Drug)
- Labetalol, Nifedipine
- Lead sponsor
- Medical College of Wisconsin
Record details
- Record id
cardio:ct-nct04298034- Content hash
f058d39cd73737c0769e291cdba0a05ae34a56cbac1df3453e72c9af05b5d050